
|Videos|March 27, 2014
PSA Testing Guidelines
Author(s)Oliver Sartor, MD
Oliver Sartor, MD, board professor, cancer research, Tulane University, discusses PSA testing guidelines.
Advertisement
Clinical Pearls
Oliver Sartor, MD, board professor, cancer research, Tulane University, discusses PSA testing guidelines.
- Rather than focus on one guideline or another, physicians should focus on a model of informed decision making
- A dichotomy exists between those that treat prostate cancer and those that do not
- PSA testing adds value but also brings a potential for harm
- Following PSA testing, a physician should be open to the concept of surveillance before making a decision
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
2
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
3
Imlunestrant Regimens Sustain Efficacy Benefit in ER+/HER2– Breast Cancer
4
Giredestrant/Everolimus Improves PFS Across Subgroups After CDK4/6i in ER+/HER2– Breast Cancer
5










































